SpineGuard Announces First Surgeries with its new “DSG Connect” Platform
29 Juin 2020 - 08:00AM
Business Wire
Regulatory News:
SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an
innovative company that deploys its DSG® (Dynamic Surgical
Guidance) sensing technology to secure and streamline the placement
of bone implants, announced today the first cases using its “DSG
Connect” platform. They were performed successfully by Prof.
Assaker and his team at the Fondation Hopale and the Centre
Hospitalier Universitaire de Lille in France a few weeks after
obtaining the CE mark in the context of the gradual resumption of
elective surgeries.
“I see immediate substantial clinical benefits in using this new
DSG Connect interface and also promising potential for future
robotic applications. While drilling my pedicles, the possibility
to visualize the audio feedback as compared to thresholds, that I
can determine by myself depending on patient bone quality and keep
in memory all along the drillings is of great help during
challenging pedicles such as sclerotic ones. Lastly, the recording
capability allows for storage of data that could become useful
after the surgery whether as evidence of good practice or for
scientific purposes,” said Richard Assaker MD, Professor of
Neurosurgery at Centre Hospitalier Universitaire de Lille,
France.
Patricia Lempereur, Sales and Marketing Director,
International of SpineGuard, said: “The DSG Connect tablet adds
great value to the physician during the spinal surgery. The
additional information provided such as graphic visualization of
the auditory feedback and visual comparative indicators,
streamlines the surgery without adding complexity. Moreover, the
“simple” and “advanced” modes offered by the App give versatility
in surgeon’s choice when using the DSG Connect.”
About SpineGuard®
Founded in 2009 in France and the USA by Pierre Jérôme and
Stéphane Bette, SpineGuard is an innovative company deploying its
proprietary radiation-free real time sensing technology DSG®
(Dynamic Surgical Guidance) to secure and streamline the placement
of implants in the skeleton. SpineGuard designs, develops and
markets medical devices that have been used in over 75,000 surgical
procedures worldwide. Fifteen studies published in peer-reviewed
scientific journals have demonstrated the multiple benefits DSG®
offers to patients, surgeons, surgical staff and hospitals.
Building on these solid fundamentals and several strategic
partnerships, SpineGuard has expanded its technology platform in a
disruptive innovation: the « smart » pedicle screw launched late
2017 and is broadening the scope of applications in dental
implantology and surgical robotics. DSG® was co-invented by Maurice
Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem,
Biomedical Engineer.
For further information, visit www.spineguard.com
Disclaimer
The SpineGuard securities may not be offered or sold in the
United States as they have not been and will not be registered
under the Securities Act or any United States state securities
laws, and SpineGuard does not intend to make a public offer of its
securities in the United States. This is an announcement and not a
prospectus, and the information contained herein does and shall not
constitute an offer to sell or the solicitation of an offer to buy,
nor shall there be any sale of the securities referred to herein in
the United States in which such offer, solicitation or sale would
be unlawful prior to registration or exemption from
registration.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200628005009/en/
SpineGuard Pierre Jérôme Président Directeur Général Tél.
: 01 45 18 45 19 p.jerome@spineguard.com
Manuel Lanfossi Directeur Financier
m.lanfossi@spineguard.com
Europe / NewCap Investor Relations & Financial
Communication Mathilde Bohin / Pierre Laurent Tél. : 01 44 71 94 94
spineguard@newcap.eu
Spineguard (EU:ALSGD)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024
Spineguard (EU:ALSGD)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024